title: Microperimetry findings in patients with birdshot chorioretinopathy.
abstract: OBJECTIVE
  To assess the role of microperimetry-1 (MP1) as an ancillary tool in patients with birdshot chorioretinopathy (BSCR).
  
  
  METHODS
  Observational cross-sectional study.
  
  
  METHODS
  Twenty-three eyes of 23 patients.
  
  
  METHODS
  A review of medical records was conducted of patients with BSCR seen at our institution, from January 2008 to August 2008, on whom MP1 had been performed. Of the 23 eyes included in the study, 15 eyes were identified as having HLA-A29 positive BSCR; 8 eyes with no known ocular pathology were used in the analysis as the control group. The clinical status was assessed by biomicroscopy, indirect ophthalmoscopy, and fluorescein angiography.
  
  
  RESULTS
  When eyes with active disease were compared with eyes with inactive disease there was a statistically significant difference (p = 0.001) between them in the number of points below 16 dB. The difference was also statistically significant (p = 0.04) when it was adjusted for visual acuity, associated disease, and age. When eyes of patients with inactive disease were compared with control eyes, there was a statistically significant difference (p = 0.01) in the number of points below 16 dB, suggesting that not all patients may recover their full retinal sensitivities. When eyes of patients with active disease were compared with controls there was a statistically significant difference (p = 0.01) between them in the number of points below 16 dB after adjusting for age, visual acuity, and associated disease (macular edema and epiretinal membrane).
  
  
  CONCLUSIONS
  Microperimetric quantification of macular sensitivity in patients with BSCR may provide an ancillary tool to evaluate activity and may help to assess visual impairment in these patients.
authors.affiliation: Massachusetts Eye Research and Surgery Institution, Cambridge, MA, USA. gpgiuliari@gmail.com
authors.forename: Gian Paolo
authors.initials: GP
authors.lastname: Giuliari
authors.forename: Siddharth
authors.initials: S
authors.lastname: Pujari
authors.forename: Mehrine
authors.initials: M
authors.lastname: Shaikh
authors.forename: Danielle
authors.initials: D
authors.lastname: Marvell
authors.forename: C Stephen
authors.initials: CS
authors.lastname: Foster
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D005189:False Positive Reactions; D005260:Female; D005403:Fixation, Ocular / Q000502:physiology; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D033401:Microscopy, Acoustic; D008875:Middle Aged; D009887:Ophthalmoscopy; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012160:Retina / Q000503:physiopathology*; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D015866:Uveitis, Posterior / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D058609:Visual Field Tests; D014794:Visual Fields / Q000502:physiology*
chemical_list: D007166:Immunosuppressive Agents